Medically Assisted Procreation and Choice of the Embryo: How Far Would French People Like to go

Infertility Clinical Trial

Official title:

Medically Assisted Procreation and Choice of the Embryo: How Far Would French People Like to go - An Opinion Survey Among Patients Resorting to in Vitro Fertilization (IVF) in France.

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT04763551
• Other study ID #: RECHMPL21_0088
• Status: Enrolling by invitation
• Start date: February 1, 2021
• Est. completion date: January 1, 2022

Study information

• Verified date: February 2021
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In today's context of bioethics laws revision concerning Medically Assisted Procreation, the investigators focus on the opinion of couples resorting to In Vitro Fertilization on a fundamental, much debated issue ; the choice of the embryo.

French lawmakers fear the investigators might be drifting towards embryo selection procedures, but no study allows us to state this is what patients request. This study aims at determining, among the population of patients who resort to Medically Assisted Procreation in France, the ratio of patients who are willing to select the embryo due to its genetic characteristics.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 300
• Est. completion date: January 1, 2022
• Est. primary completion date: December 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

• Male and female IVF patients in the MAP

Exclusion criteria:

• Patient not fluent in French

Related Conditions & MeSH terms

• Infertility

Locations

Country	Name	City	State
France	Uhmontpellier	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of Medically Assisted Procreation	Determine, among the population of patients who resort to Medically Assisted Procreation in France, the ratio of patients who are willing to select the embryo due to its genetic characteristics	1 day
Secondary	Determine the type of embryo genetic selection	Determine the type of embryo genetic selection those patients request	1 day
Secondary	Determine, among the population of patients who resort to Medically Assisted Procreation in France	Determine, among the population of patients who resort to Medically Assisted Procreation in France, the ratio of patients who are willing to select the embryo due to its genetic characteristics, according to the type of MAP (classical MAP, with or without gamete donation, MAP with PGD)	1 day